Professor Reubinoff is one of the pioneers of human embryonic stem cell (hESC) research. In collaboration with scientists from Monash University in Melbourne and the National University of Singapore, he was the second in the world to derive human embryonic stem cell (hESC) lines and was the first to show somatic differentiation of the hESCs in culture. Prof. Reubinoff is the founder and director of the Sidney and Judy Swartz Human Embryonic Stem Cell Research Center and a full professor and chairman of the Department of Obstetrics and Gynecology at the Hadassah University Medical Center in Jerusalem. The focus of Prof. Reubinoff’s research is the exploitation of human embryonic stem cells (hESCs) in regenerative medicine for the treatment of neural and retinal degenerative disorders. He is the founder of Cell Cure Neurosciences Ltd. and has been the Chief Scientific Officer since 2006. He is also a member of the Scientific Advisory Board at Kadimastem Ltd. His work on human pluripotent stem cells helped lead to the development of programs that are now in clinical trials in Israel.